EGFR mutations as a predictive marker of cytotoxic chemotherapyJIN HYUN PARKA; LEE, Se-Hoon; KEAM, Bhumsuk et al.Lung cancer. 2012, Vol 77, Num 2, pp 433-437, issn 0169-5002, 5 p.Article

Synchronous multiple primary lung cancers with different response to gefitinibRYOO, Baek-Yeol; IM II NA; SUNG HYUN YANG et al.Lung cancer. 2006, Vol 53, Num 2, pp 245-248, issn 0169-5002, 4 p.Article

Translational studies for target-based drugsNISHIO, Kazuto; ARAO, Tokuzo; SHIMOYAMA, Tatsu et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, issn 0344-5704, s90-s93, SUP1Article

Bronchoscopic Microsampling is a Useful Complementary Diagnostic Tool for Detecting Lung CancerYASUDA, Hiroyuki; SOEJIMA, Kenzo; WATANABE, Hideo et al.Lung cancer. 2011, Vol 72, Num 1, pp 32-38, issn 0169-5002, 7 p.Article

A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancerKAWAHARA, Akihiko; TAIRA, Tomoki; HAYASHI, Akihiro et al.Lung cancer. 2012, Vol 78, Num 1, pp 39-44, issn 0169-5002, 6 p.Article

Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistanceMASSARELLI, Erminia; JOHNSON, Faye M; ERICKSON, Heidi S et al.Lung cancer. 2013, Vol 80, Num 3, pp 235-241, issn 0169-5002, 7 p.Article

Epidermal growth factor receptor (EGFR) : Mutational and protein expression analysis in gastric cancerMAMMANO, Enzo; BELLUCO, Claudio; SCIRO, Manuela et al.Anticancer research. 2006, Vol 26, Num 5A, pp 3547-3550, issn 0250-7005, 4 p.Article

EGFR mutations and the terminal respiratory unit : Lung cancerYATABE, Yasushi.Cancer metastasis reviews. 2010, Vol 29, Num 1, pp 23-36, issn 0167-7659, 14 p.Article

Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patientsSUEOKA, Naoko; SATO, Akemi; EGUCHI, Hidetaka et al.Journal of cancer research and clinical oncology. 2007, Vol 133, Num 2, pp 93-102, issn 0171-5216, 10 p.Article

Duration of prior gefitinib treatment predicts survival potential in patients with lung adenocarcinoma receiving subsequent erlotinibASAMI, Kazuhiro; KAWAHARA, Masaaki; ATAGI, Shinji et al.Lung cancer. 2011, Vol 73, Num 2, pp 211-216, issn 0169-5002, 6 p.Article

EGFR mutation in various tissuesNISHIO, Kazuto; ARAO, Tokuzo; KATO, Terufumi et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, issn 0344-5704, s39-s41, SUP1Conference Paper

Icotinib (BPI-2009H), a novel EGFR tyrosine kinase inhibitor, displays potent efficacy in preclinical studiesFENLAITAN; XIAOYAN SHEN; DECHANG WANG et al.Lung cancer. 2012, Vol 76, Num 2, pp 177-182, issn 0169-5002, 6 p.Article

Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinomaHASANOVIC, Adnan; ANG, Daphne; MOREIRA, Andre L et al.Lung cancer. 2012, Vol 77, Num 2, pp 299-305, issn 0169-5002, 7 p.Article

Frequent EGFR mutations in noninvasive bronchioloalveolar carcinomaMATSUMOTO, Shingo; IWAKAWA, Reika; KOHNO, Takashi et al.International journal of cancer. 2006, Vol 118, Num 10, pp 2498-2504, issn 0020-7136, 7 p.Article

Genetic alterations in primary glioblastomas in JapanFUKUSHIMA, Takao; FAVEREAUX, Alexandre; HUANG, Hervé et al.Journal of neuropathology and experimental neurology. 2006, Vol 65, Num 1, pp 12-18, issn 0022-3069, 7 p.Article

Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR―TKI for adenocarcinoma of the lungNOSE, Naohiro; URAMOTO, Hidetaka; IWATA, Teruo et al.Lung cancer. 2011, Vol 71, Num 3, pp 350-355, issn 0169-5002, 6 p.Article

Detection of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) using a fully automated system with a nano-scale engineered biomagnetiteMARUYAMA, Kohei; TAKEYAMA, Haruko; MORI, Tetsushi et al.Biosensors & bioelectronics. 2007, Vol 22, Num 9-10, pp 2282-2288, issn 0956-5663, 7 p.Conference Paper

Clinical development of EGFR-tyrosine kinase inhibitors in JapanNAKAGAWA, Kazuhiko.Cancer chemotherapy and pharmacology. 2006, Vol 58, issn 0344-5704, s33-s37, SUP1Conference Paper

Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patientsTANAKA, Aya; SUEOKA-ARAGANE, Naoko; NAKAMURA, Tomomi et al.Lung cancer. 2012, Vol 75, Num 1, pp 89-94, issn 0169-5002, 6 p.Article

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3BORGET, I; CADRANEL, J; DANIEL, C et al.The European respiratory journal. 2012, Vol 39, Num 1, pp 172-179, issn 0903-1936, 8 p.Article

Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutationsWU, Shang-Gin; YANG, Chih-Hsin; YU, Chong-Jen et al.Lung cancer. 2011, Vol 72, Num 3, pp 333-339, issn 0169-5002, 7 p.Article

Structural analysis of the EGFR TK domain and potential implications for EGFR targeted therapyWEIWEI NIE; LIN TANG; HAIYANG ZHANG et al.International journal of oncology. 2012, Vol 40, Num 6, pp 1763-1769, issn 1019-6439, 7 p.Article

Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutationTAJA-CHAYEB, Lucia; CANDELARIA, Myrna; BROM, Rocio et al.Lung cancer. 2005, Vol 50, Num 2, pp 259-263, issn 0169-5002, 5 p.Article

Afatinib for the treatment of advanced non-small-cell lung cancerGENOVA, Carlo; RIJAVEC, Erika; GROSSI, Francesco et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 6, pp 889-903, issn 1465-6566, 15 p.Article

Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancerKIMURA, Hideharu; OHIRA, Tatsuo; UCHIDA, Osamu et al.Lung cancer. 2014, Vol 83, Num 3, pp 329-333, issn 0169-5002, 5 p.Article